SavedAdd your journal

Journals / Türk Geriatri Dergisi / 2020 / Cilt: 23 - Sayı: 4

THE EFFECT OF SURGICAL TREATMENT ON SURVIVAL IN GERIATRIC PATIENTS WITH STAGE I SMALL-CELL LUNG CANCER

Aslı KILAVUZ
Hakan ÇELİKHISAR
Gülay İlkhan DAŞDEMİR
Pages
455–462
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Overall survival and lung cancer-specific survival were evaluated amongthese 3 groups.Results: A total of 1248 patients were included in the study. 28.9% of thepatients did not receive any treatments, 47.2% of the patients received non-surgicaltreatment and 23.9% of the patients received surgical treatment.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: The aim of our study is to investigate the effects of early stagesurgical treatment on the survival of the geriatric patient group in small cell lungcancer.Materials and Method: Patients over 65 years of age with a diagnosis of stageI small cell lung cancer were included.
📊
Key Findings & Data:The patients included in the study weredivided into three groups. 1.
💡
Conclusion & Impact:Overall survival and lung cancer-specific survival were evaluated amongthese 3 groups.Results: A total of 1248 patients were included in the study. 28.9% of thepatients did not receive any treatments, 47.2% of the patients received non-surgicaltreatment and 23.9% of the patients received surgical treatment.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Introduction: The aim of our study is to investigate the effects of early stagesurgical treatment on the survival of the geriatric patient group in small cell lungcancer.Materials and Method: Patients over 65 years of age with a diagnosis of stageI small cell lung cancer were included. The patients included in the study weredivided into three groups. 1. The surgical group 2. Non-surgical group 3. Untreatedgroup. Overall survival and lung cancer-specific survival were evaluated amongthese 3 groups.Results: A total of 1248 patients were included in the study. 28.9% of thepatients did not receive any treatments, 47.2% of the patients received non-surgicaltreatment and 23.9% of the patients received surgical treatment. The 5-year overallsurvival rates of the untreated group, non-surgical group and surgical group were7%, 10% and 32%, respectively (p

🔖

Cite This Article

KILAVUZ, A., ÇELİKHISAR, H., DAŞDEMİR, G. İ. (2022). THE EFFECT OF SURGICAL TREATMENT ON SURVIVAL IN GERIATRIC PATIENTS WITH STAGE I SMALL-CELL LUNG CANCER. Türk Geriatri Dergisi, Cilt: 23 - Sayı: 4, 455–462. https://ajindex.com/articles/624085

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Low M, Ben-Or S. Thoracic surgery in early-stage small cell lung cancer. Thorac Surg Clin 2018;28(1):9- 14. (PMID: 29150041)
  2. Huang C-Y, Au K-K, Chen S-L, Wang S-C, Liao C-Y, Hsu H-H, Sung W-W, Wang Y-C. Unfavorable Mortality-To-Incidence Ratio of Lung Cancer Is Associated with Health Care Disparity. International Journal of Environmental Research and Public Health. 2018; 15(12):2889
  3. Garon EB, Hellmann MD, Rizvi NA, Carcereny E, Leighl NB, Ahn MJ, Eder JP, Balmanoukian AS, Aggarwal C, Horn L, Patnaik A, Gubens M, Ramalingam SS, Felip E, Goldman JW, Scalzo C, Jensen E, Kush DA, Hui R. Five-Year Overall Survival for Patients with Advanced Non‒Small-Cell Lung Cancer Treated with Pembrolizumab: Results From the Phase I KEYNOTE-001 Study. J Clin Oncol. 2019 Oct 1;37(28):2518-2527. doi: 10.1200/JCO.19.00934. Epub 2019 Jun 2. PMID: 31154919; PMCID: PMC6768611
  4. Du X, Tian D, Liu L, et al. Surgery in patients with small cell lung cancer: A period propensity score matching analysis of the Seer database, 2010-2015. Oncol Lett 2019;18(5):4865-81. (PMID: 31611997)
  5. Shepherd FA, Ginsberg R, Patterson GA, et al. Is there ever a role for salvage operations in limited small-cell lung cancer? J Thorac Cardiovasc Surg 1991;101(2):196-200. (PMID: 1846927)
  6. Matsumoto Y, Ohara S, Furukawa R, Usui K. The Prognosis of Small Cell Lung Cancer in Patients with Pulmonary Fibrosis. Anticancer Res. 2017 Oct;37(10):5791-5795. doi: 10.21873/anticanres.12021. PMID: 28982903
  7. Govindan R, Page N, Morgensztern D, et al. Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database. J Clin Oncol 2006;24(28):4539-44. (PMID: 17008692)
  8. Wang Z, Pang L, Tang J, et al. Video-assisted thoracoscopic surgery versus muscle-sparing thoracotomy for non-small cell lung cancer: a systematic review and meta-analysis. BMC Surg 2019;19(1):144. (PMID: 31615490)
  9. Zhong L, Suo J, Wang Y, et al. Prognosis of limited-stage small cell lung cancer with comprehensive treatment including radical resection. World J Surg Oncol 2020;18(1):27. (PMID: 32013993)
  10. Tjong MC, Mak DY, Shahi J, Li GJ, Chen H, Louie AV. Current management and progress in radiotherapy for small cell lung cancer. Front Oncol 2020; 10:1146. (PMID: 32760673)
  11. Repetto L, Fratino L, Audisio RA, et al. Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elder